Repeated infliximab therapy after serum sickness-like reaction in Crohn's disease.
Miheller
Pál
P
Muzes
Györgyi
G
Lakatos
Gábor
G
Mihály
Emese
E
Tulassay
Zsolt
Z
D000328:Adult; D000893:Anti-Inflammatory Agents / Q000009:adverse effects*; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D003424:Crohn Disease / Q000188:drug therapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000139:chemically induced* / Q000276:immunology; D000069285:Infliximab; D008297:Male; D012713:Serum Sickness / Q000139:chemically induced* / Q000276:immunology
D000893:Anti-Inflammatory Agents; D000911:Antibodies, Monoclonal; D000069285:Infliximab